Multicare Health System
Multicare Health System was paid $31.02M by Medicaid between Jan 2018 and Dec 2024, across 273 billing codes. Its largest line is 96361, Intravenous infusion, hydration; each additional hour — 16% of everything it billed.
AUBURN, WA 98001
Next to other General Acute Care Hospital providers in Washington
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 154,485 | $4.26M | |
| 2019 | 163,115 | $4.50M | |
| 2020 | 139,822 | $3.74M | |
| 2021 | 169,863 | $4.41M | |
| 2022 | 175,407 | $5.55M | |
| 2023 | 164,475 | $4.62M | |
| 2024incomplete | 138,782 | $3.94M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 96361 | Intravenous infusion, hydration; each additional hour | 16% | 16,828 | 14,804 | $5.02M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 16% | 43,872 | 41,343 | $4.86M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 11% | 44,994 | 41,047 | $3.56M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 10% | 35,773 | 33,511 | $3.25M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.8% | 9,192 | 8,852 | $1.49M |
| 70450 | Computed tomography, head or brain; without contrast material | 4.2% | 9,708 | 9,147 | $1.30M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 3.6% | 20,987 | 12,691 | $1.12M |
| 59025 | Fetal non-stress test | 2.9% | 6,094 | 4,549 | $895K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.7% | 8,914 | 8,469 | $842K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 2.1% | 2,631 | 2,255 | $647K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.7% | 6,156 | 5,762 | $528K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.6% | 4,334 | 4,200 | $512K |
261 more codes
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.5% | 2,703 | $459K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.4% | 20,716 | $421K |
| 29581 | 1.2% | 2,665 | $372K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 1.2% | 4,575 | $371K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1.1% | 2,144 | $334K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 8,630 | $298K |
| 80053 | Comprehensive metabolic panel | <1% | 60,420 | $264K |
| 76830 | Ultrasound, transvaginal | <1% | 3,018 | $254K |
| 10060 | <1% | 1,086 | $218K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 2,539 | $200K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 3,878 | $191K |
| 76801 | <1% | 3,721 | $181K | |
| 12001 | <1% | 792 | $168K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 1,030 | $165K |
| 70496 | <1% | 766 | $138K | |
| 93971 | <1% | 1,539 | $135K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,372 | $126K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 18,570 | $99K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 309 | $96K |
| 87400 | <1% | 8,652 | $96K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 205 | $95K |
| 84484 | <1% | 20,394 | $87K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 1,355 | $84K |
| 97597 | <1% | 1,630 | $84K | |
| 95800 | <1% | 290 | $77K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 1,769 | $76K |
| 76770 | <1% | 850 | $75K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 2,133 | $54K |
| 12011 | <1% | 251 | $54K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 2,053 | $53K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 744 | $49K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 6,190 | $48K |
| 70491 | <1% | 324 | $46K | |
| 73564 | <1% | 3,740 | $45K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 188 | $44K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 30,913 | $43K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 4,019 | $41K |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 1,170 | $41K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 9,609 | $39K |
| G0378 | Hospital observation service, per hour | <1% | 4,173 | $37K |
| 76536 | <1% | 407 | $35K | |
| 70486 | <1% | 1,076 | $34K | |
| 72100 | <1% | 2,894 | $34K | |
| 0011A | <1% | 1,193 | $33K | |
| 87040 | <1% | 5,305 | $33K | |
| 11043 | <1% | 96 | $32K | |
| 95811 | <1% | 83 | $31K | |
| 83605 | <1% | 6,436 | $31K | |
| 73630 | <1% | 3,412 | $30K | |
| 0012A | <1% | 777 | $30K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 31,749 | $30K |
| 0002A | <1% | 768 | $29K | |
| 94060 | <1% | 666 | $28K | |
| 0001A | <1% | 951 | $28K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 2,970 | $27K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 10,767 | $26K |
| 83880 | <1% | 5,377 | $26K | |
| 64400 | <1% | 88 | $24K | |
| 73130 | <1% | 2,744 | $24K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 447 | $24K |
| 70498 | <1% | 890 | $23K | |
| 74018 | <1% | 1,607 | $23K | |
| 73110 | <1% | 1,973 | $23K | |
| 87420 | <1% | 1,173 | $23K | |
| 73030 | <1% | 2,742 | $22K | |
| 94729 | <1% | 983 | $22K | |
| 80143 | <1% | 5,034 | $22K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 239 | $21K |
| 94726 | <1% | 920 | $20K | |
| 90715 | <1% | 1,118 | $20K | |
| 73610 | <1% | 2,682 | $20K | |
| 85379 | <1% | 4,394 | $20K | |
| 76870 | <1% | 220 | $18K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 401 | $18K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 111 | $17K |
| 87631 | <1% | 889 | $16K | |
| 73140 | <1% | 1,015 | $14K | |
| 95806 | <1% | 29 | $14K | |
| 29125 | <1% | 91 | $14K | |
| 12002 | <1% | 69 | $14K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 68,335 | $13K |
| 73502 | <1% | 1,517 | $13K | |
| 71250 | <1% | 249 | $12K | |
| 72040 | <1% | 1,087 | $12K | |
| 80179 | <1% | 4,967 | $11K | |
| 71045 | Radiologic examination, chest; single view | <1% | 11,105 | $11K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 22,559 | $10K |
| 93970 | <1% | 110 | $9K | |
| 93798 | <1% | 1,234 | $8K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 242 | $7K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 42 | $6K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 127 | $6K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 13 | $6K |
| 73590 | <1% | 861 | $6K | |
| 73080 | <1% | 924 | $6K | |
| J3490 | Unclassified drugs | <1% | 208 | $6K |
| 36592 | <1% | 24,801 | $5K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 14,084 | $5K |
| 80050 | General health panel | <1% | 854 | $5K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 175 | $5K |
| 36415 | Collection of venous blood by venipuncture | <1% | 11,367 | $5K |
| 72072 | <1% | 438 | $4K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 39 | $4K |
| 84703 | <1% | 16,972 | $4K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 13 | $4K |
| 96376 | <1% | 7,638 | $3K | |
| 81001 | <1% | 28,365 | $3K | |
| 85610 | <1% | 13,934 | $3K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 16,201 | $3K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 4,015 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 10,224 | $3K |
| 85027 | <1% | 2,888 | $3K | |
| 82077 | <1% | 8,696 | $2K | |
| 71101 | <1% | 380 | $2K | |
| 97161 | <1% | 65 | $2K | |
| 83690 | <1% | 13,991 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 20,484 | $2K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 16,428 | $2K |
| 84702 | <1% | 4,272 | $2K | |
| 93017 | <1% | 13 | $2K | |
| 82962 | <1% | 6,781 | $1K | |
| 73090 | <1% | 399 | $1K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 131 | $1K |
| 96367 | <1% | 145 | $1K | |
| 83735 | <1% | 5,855 | $1K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 7,676 | $1K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,647 | $1K |
| 87070 | <1% | 7,841 | $1K | |
| 87430 | <1% | 6,081 | $1K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 79 | $1K |
| P9016 | Red blood cells, leukocytes reduced, each unit | <1% | 13 | $1K |
| 87186 | <1% | 4,680 | $1K | |
| 81003 | <1% | 15,738 | $1K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 7,374 | $1K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 2,846 | $995.35 |
| 87808 | <1% | 2,933 | $973.31 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 4,306 | $833.59 |
| 81025 | <1% | 5,529 | $827.22 | |
| C1729 | Catheter, drainage | <1% | 497 | $819.75 |
| 73120 | <1% | 31 | $745.56 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,063 | $722.73 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 8,461 | $677.28 |
| 94010 | <1% | 38 | $600.02 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 8,207 | $577.55 |
| 76937 | <1% | 15 | $553.30 | |
| 80076 | <1% | 198 | $546.28 | |
| 36416 | <1% | 6,956 | $541.14 | |
| 86140 | <1% | 3,191 | $531.66 | |
| 84112 | <1% | 66 | $520.15 | |
| 87205 | <1% | 5,045 | $466.13 | |
| 86780 | <1% | 156 | $445.26 | |
| 0031A | <1% | 12 | $437.99 | |
| 82550 | <1% | 1,617 | $430.98 | |
| 86900 | <1% | 2,462 | $424.12 | |
| 86850 | <1% | 1,871 | $401.60 | |
| 90686 | <1% | 42 | $400.55 | |
| C1769 | Guide wire | <1% | 578 | $389.40 |
| 74019 | <1% | 90 | $369.67 | |
| 88307 | <1% | 13 | $365.59 | |
| 87077 | <1% | 2,894 | $362.19 | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 486 | $344.42 |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 581 | $340.10 |
| 86901 | <1% | 2,924 | $318.77 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 4,728 | $302.71 |
| 96368 | <1% | 39 | $282.19 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 4,371 | $281.50 |
| 99152 | <1% | 1,062 | $281.49 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 293 | $274.72 |
| 85730 | <1% | 3,681 | $256.65 | |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 1,049 | $255.83 |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 1,340 | $253.99 |
| 73660 | <1% | 25 | $246.00 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 2,486 | $240.29 |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 27 | $229.73 |
| A4649 | Surgical supply; miscellaneous | <1% | 1,438 | $222.21 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 3,843 | $212.65 |
| 84145 | <1% | 25 | $203.14 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 6,517 | $199.52 |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 2,066 | $192.32 |
| J2704 | Injection, propofol, 10 mg | <1% | 6,125 | $184.89 |
| 85014 | <1% | 492 | $181.46 | |
| 80047 | <1% | 62 | $177.82 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 5,377 | $165.83 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 6,128 | $160.37 |
| 88304 | <1% | 1,010 | $155.39 | |
| 85651 | <1% | 2,145 | $148.09 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 1,738 | $145.00 |
| 82010 | <1% | 1,057 | $115.59 | |
| 84100 | <1% | 494 | $111.19 | |
| 90674 | <1% | 12 | $97.81 | |
| 85018 | <1% | 158 | $83.93 | |
| 87210 | <1% | 700 | $83.50 | |
| 72170 | <1% | 57 | $81.54 | |
| 80164 | <1% | 16 | $80.82 | |
| 74022 | <1% | 25 | $79.89 | |
| 80305 | <1% | 203 | $64.50 | |
| 82570 | <1% | 293 | $56.43 | |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 809 | $49.70 |
| 82805 | <1% | 330 | $48.93 | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 61 | $45.94 |
| 84550 | <1% | 277 | $43.33 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 1,121 | $38.93 |
| 84156 | <1% | 288 | $31.58 | |
| 88342 | <1% | 71 | $23.65 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 1,948 | $20.80 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 2,419 | $20.58 |
| 99153 | Mod sedat endo service >5yrs | <1% | 237 | $17.49 |
| 85007 | <1% | 90 | $14.11 | |
| 86308 | <1% | 66 | $13.94 | |
| 87149 | <1% | 111 | $12.77 | |
| 80061 | Lipid panel | <1% | 72 | $11.69 |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 326 | $10.45 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 968 | $10.02 |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 377 | $7.09 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 229 | $6.99 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 2,704 | $6.65 |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | <1% | 76 | $6.30 |
| 87184 | <1% | 29 | $6.14 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 159 | $5.86 |
| 89051 | <1% | 99 | $5.60 | |
| J1920 | Injection, labetalol hydrochloride, 5 mg | <1% | 32 | $4.25 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | <1% | 345 | $4.22 |
| 51798 | <1% | 32 | $2.99 | |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | <1% | 483 | $2.51 |
| J1815 | Injection, insulin, per 5 units | <1% | 2,466 | $1.34 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 27 | $0.08 |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | <1% | 233 | $0.07 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 1,059 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 0% | 138 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 103 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 361 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 9,152 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 864 | $0.00 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 0% | 231 | $0.00 |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 0% | 13 | $0.00 |
| 91300 | 0% | 1,561 | $0.00 | |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 0% | 55 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 39 | $0.00 |
| 84439 | 0% | 14 | $0.00 | |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 0% | 89 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 136 | $0.00 |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 0% | 44 | $0.00 |
| J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | 0% | 62 | $0.00 |
| 87806 | 0% | 12 | $0.00 | |
| 80074 | 0% | 13 | $0.00 | |
| A9541 | Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries | 0% | 12 | $0.00 |
| J3411 | Injection, thiamine hcl, 100 mg | 0% | 136 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 214 | $0.00 |
| 87081 | 0% | 28 | $0.00 | |
| J3360 | Injection, diazepam, up to 5 mg | 0% | 44 | $0.00 |
| J1836 | Injection, metronidazole, 10 mg | 0% | 58 | $0.00 |
| 82330 | 0% | 31 | $0.00 | |
| A4351 | Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, or silicone elastomer, etc.), each | 0% | 13 | $0.00 |
| 91301 | 0% | 1,910 | $0.00 | |
| 73060 | 0% | 12 | $0.00 | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 0% | 26 | $0.00 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 17 | $0.00 |
| 77001 | 0% | 12 | $0.00 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 31 | $0.00 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 0% | 21 | $0.00 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Multicare Health System | Tacoma, WA | $162.25M |
| Multicare Health System | Tacoma, WA | $108.54M |
| Yakima Valley Memorial Hospital Association | Yakima, WA | $103.54M |
| Multicare Health System | Puyallup, WA | $77.99M |
| Multicare Health System | Tacoma, WA | $75.17M |
| Greater Lakes Mental Health Foundation INC | Lakewood, WA | $55.95M |
| Multicare Health System | Spokane, WA | $55.23M |
| Multicare Health System | Spokane Valley, WA | $24.75M |
| Multicare Health System | Covington, WA | $23.19M |
| Multicare Health System | Olympia, WA | $16.97M |
| Multicare Health System | Tacoma, WA | $11.14M |
| Multicare Health System | Auburn, WA | $7.42M |
| Multicare Health System | Tacoma, WA | $2.68M |
| Alliance for South Sound Health | Tacoma, WA | $2.46M |
| Capital Medical Center Physicians LLC | Olympia, WA | $1.75M |
| Multicare Health System | Tacoma, WA | $1.53M |
| Yakima Valley Memorial Hospital Association | Yakima, WA | $1.16M |
| Capital Medical Center Specialty Physicians, LLC | Olympia, WA | $987K |
| Yakima Urology at Memorial TR | Yakima, WA | $784K |
| Multicare Health System | Spokane, WA | $179K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.